Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice

Infection and Immunity

Volumn 69, Issue 4, 2001, Pages 2277-2285

  Rath, H C ^a   Schultz, M ^a   Freitag, R ^a   Dieleman, L A ^a   Li, F ^a   Linde, H J ^a   Scholmerich J ^a   Sartor, R B ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CIPROFLOXACIN; DEXTRAN SULFATE; HLA B27 ANTIGEN; IMIPENEM; INTERLEUKIN 1BETA; METRONIDAZOLE; VANCOMYCIN;

AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTEROIDES; CECUM; COLITIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INTESTINE FLORA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; TRANSGENIC ANIMAL;

ANIMALS; BACTEROIDES; CIPROFLOXACIN; COLITIS; ENTEROBACTERIACEAE; FEMALE; HLA-B27 ANTIGEN; IMIPENEM; INTERLEUKIN-1; METRONIDAZOLE; MICE; MICE, INBRED BALB C; RATS; RATS, INBRED F344; VANCOMYCIN;

EID: 0035082973     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.4.2277-2285.2001     Document Type: Article

References (54)

1. Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients
2. Metronidazole inhibits leukocyte-endothelial cell adhesion in rat mesenteric venules
3. Ciprofloxacin in active Crohn's disease: Preliminary report of a six month randomized placebo controlled study
4. Experimental colitis induced by dextran sulphate sodium in mice: Beneficial effects of sulphasalazine and olsalazine
5. Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: Effects in CD4(+) -cell depleted, athymic and NK- cell depleted SCID mice
6. The role of intestinal bacteria, bacterial translocation and endotoxin in dextran sodium sulphate-induced colitis in the mouse
7. Effects of antibiotics on the initiation and perpetuation of colitis in the IL-10 KO mice
8. Hepatic effects of jejunoileal bypass for morbid obesity
9. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease
10. Comparative study on the in vivo efficacy of metronidazole, aztreonam and amoxycillin/clavulanic acid in the indomethacin model: Evidence for immune-modulatory properties of metronidazole
11. CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: Increased T helper cell type 1 response and ability to transfer disease
12. Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice
13. T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment
14. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice
15. Hepatic steatosis after intestinal bypass - Prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition
16. Incrimination of anaerobic bacteria in the induction of experimental colitis
17. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis
18. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: An animal model of HLA-B27-associated human disorders
19. The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice
20. Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice
21. Clinical effect of metronidazole and sulfasalazine on Crohn's disease in relation to changes in the fecal flora
22. Interleukin-10-deficient mice develop chronic enterocolitis
23. Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline
24. Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth
25. Reactivation of arthritis induced by small bowel bacterial overgrowth in rats: Role of cytokines, bacteria, and bacterial polymers
26. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice
27. Stimulation of transforming growth factor betal by enteric bacteria in the pathogenesis of rat intestinal fibrosis
28. Changes in bacterial phagocytosis of macrophages in experimental ulcerative colitis
29. Protective effect of metronidazole in experimental ulcerative colitis induced by dextran sulfate sodium
30. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice
31. Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora
32. Protective effect of metronidazole in experimental ulcerative colitis
33. Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease
34. Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin
35. An antibiotic regimen for the treatment of active Crohn's disease: A randomized, controlled clinical trial of metronidazole plus ciprofloxacin
36. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats
37. Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats
38. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli
39. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection
40. Insights into the pathogenesis of inflammatory bowel disease provided by new rodent models of spontaneous colitis
41. Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis and experimental intestinal inflammation
42. Colitis in HLA-B27/beta 2 microglobulin transgenic rats
43. Microbial factors in chronic intestinal inflammation
44. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation
45. Normal enteric flora are necessary for the development of spontaneous colitis and immune system activation in IL-10 deficient mice
46. Double blind, placebo controlled trial of metronidazole in Crohn's disease
47. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression
48. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats
49. The role of bacterial microflora in the development of dextran sodium sulphate (DSS) induced colitis in immunocompetent and immunodeficient mice
50. Long-term treatment of ulcerative colitis with ciprofloxacin: A prospective, double-blind, placebo-controlled study
51. 26 mice after bone marrow transplantation or adoptive transfer
52. Role of intestinal microflora in chronic inflammation and ulceration of the rat colon
53. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin